XTX Topco Ltd Buys Shares of 375,948 Kenvue Inc. $KVUE

XTX Topco Ltd bought a new position in Kenvue Inc. (NYSE:KVUE) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 375,948 shares of the company’s stock, valued at approximately $7,869,000. Kenvue makes up approximately 0.3% of XTX Topco Ltd’s investment portfolio, making the stock its 28th largest holding.

A number of other hedge funds and other institutional investors have also recently modified their holdings of KVUE. Steward Partners Investment Advisory LLC boosted its position in shares of Kenvue by 137.9% during the second quarter. Steward Partners Investment Advisory LLC now owns 107,733 shares of the company’s stock valued at $2,255,000 after buying an additional 62,444 shares during the last quarter. Insigneo Advisory Services LLC lifted its stake in Kenvue by 46.7% during the 2nd quarter. Insigneo Advisory Services LLC now owns 23,555 shares of the company’s stock valued at $493,000 after acquiring an additional 7,496 shares during the period. Summit Global Investments purchased a new stake in shares of Kenvue during the 2nd quarter valued at about $548,000. Ameritas Investment Partners Inc. boosted its holdings in shares of Kenvue by 2.3% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 191,179 shares of the company’s stock valued at $3,999,000 after acquiring an additional 4,315 shares during the last quarter. Finally, Global Retirement Partners LLC bought a new stake in shares of Kenvue in the second quarter worth approximately $974,000. 97.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft set a $18.00 target price on shares of Kenvue in a report on Friday, October 24th. Canaccord Genuity Group reissued a “hold” rating and set a $15.00 price target (down from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. Redburn Partners set a $22.00 price target on Kenvue in a research note on Friday, September 26th. JPMorgan Chase & Co. cut their price objective on Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a report on Tuesday, October 14th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $20.23.

Kenvue Trading Up 1.1%

NYSE:KVUE opened at $16.83 on Tuesday. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The business has a fifty day moving average price of $16.14 and a 200-day moving average price of $19.72. The firm has a market capitalization of $32.24 billion, a price-to-earnings ratio of 22.44 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The firm had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same period in the previous year, the firm earned $0.28 EPS. The business’s quarterly revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be issued a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date is Wednesday, November 12th. Kenvue’s payout ratio is currently 110.67%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.